Head and Neck Diseases by Alexandros G.Sfakianakis: Immune-Related Adverse Events—A Novel Prediction of Nivolumab Efficacy?

Πέμπτη 31 Μαΐου 2018

Immune-Related Adverse Events—A Novel Prediction of Nivolumab Efficacy?

To the Editor Based on a retrospective study, Haratani et al recently revealed that the occurrence of immune-related adverse events (irAEs) could potentially predict the survival benefit in patients with advanced/recurrent non–small cell lung cancer receiving nivolumab.

https://ift.tt/2LbM3Lc

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Πέμπτη 31 Μαΐου 2018

Immune-Related Adverse Events—A Novel Prediction of Nivolumab Efficacy?

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου